Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
bFGF hydrogel versus dexamethasone sponge after facial nerve decompression for severe facial paralysis
jRCTs061220098Recruiting
- Sponsor
- Nikke
- Start
- Apr 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of trafermin and dexamethasone in Bell's palsy, herpes zoster oticus (RHS) and facial palsy (2 arms), sponsored by Nikke. Primary endpoint: Good recovery rate at 1 year after onset. Started Apr 2023; status: recruiting.
02
Drugs
trafermindexamethasone
03
Conditions
Bell's palsyherpes zoster oticus (RHS)facial palsy
Beyond the preview
Go deeper on jRCTs061220098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs061220098.